* Diebold Nixdorf Inc DBD.N DBD is expected to show a
fall in
quarterly revenue when it reports results on May 10.
* The North Canton Ohio-based company is expected to report
a
2.0% decrease in revenue to $925.125 million from $943.9 million
a year ago, according to the mean estimate from 4 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Diebold Nixdorf Inc
is
for a loss of 20 cents per share. For the same quarter last
year, the company reported earnings of 29 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Diebold
Nixdorf
Inc is $10, above its last closing price of $4.00.
* Previous quarterly performance (using preferred earnings
measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2021 0.56 0.57 0.06 Missed -89.4
Sep. 30 2021 0.51 0.51 0.34 Missed -33.3
Jun. 30 2021 0.28 0.28 0.10 Missed -64.6
Mar. 31 2021 0.18 0.20 0.29 Beat 42.6
Dec. 0.36 0.36 0.44 Beat 23.4
31 2020
Sep. 30 2020 0.23 0.23 0.28 Beat 21.7
Jun. 30 2020 0.04 0.01 0.38 Beat 5,597.
2
Mar. 31 2020 -0.31 -0.28 -0.34 Missed -21.4
This summary was machine generated May 6 at 18:38 GMT. All
figures in US dollars unless otherwise stated